Vimarsana
Biggest News Aggregation in the World

Page 6 - Growth Factor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Growth Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Growth Factor Today - Breaking & Trending Today

Study suggests CT imaging with automated AI system predicts EGFR genotype, identifying mutation status cost-effectively and non-invasively - Vimarsana News

Study suggests CT imaging with automated AI system predicts EGFR genotype, identifying mutation status cost-effectively and non-invasively

Researchers developed an artificial intelligence (AI)-based predictive system (AIPS) model for the early detection of lung cancer by combining radiological, clinical, and genetic data.

Novel three-drug combo shows promise in advanced HER2-negative breast cancer treatment - Vimarsana News

Novel three-drug combo shows promise in advanced HER2-negative breast cancer treatment

A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center.

New treatment targeting aging cells could offer lasting relief for diabetic macular edema - Vimarsana News

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.

Repeat PlGF testing for pre-eclampsia not beneficial, research finds - Vimarsana News

Repeat PlGF testing for pre-eclampsia not beneficial, research finds

A single test to speed up diagnosis of a serious disease in pregnant women does not need to be repeated, new research has found.

Study shines light on partial endothelial-to-mesenchymal transition in the tumor microenvironment - Vimarsana News

Study shines light on partial endothelial-to-mesenchymal transition in the tumor microenvironment

Endothelial-mesenchymal transition (EndoMT, also termed as EndMT), a biological process resulting in the formation of mesenchymal (or lineage-committed) phenotypes from endothelial cells (lining blood vessels), plays a crucial role in tumor progression.